Ignite Creation Date:
2024-05-05 @ 11:23 PM
Last Modification Date:
2024-10-26 @ 10:32 AM
Study NCT ID:
NCT01314898
Status:
COMPLETED
Last Update Posted:
2011-07-06
First Post:
2011-03-03
Brief Title:
A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Phase 1 Double-Blind Sponsor-Open Placebo- And Active-Controlled Single Dose Crossover Study To Assess Antimineralocorticoid Activity Of Oral Pf-03882845 In Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
24-hr urinary sodiumpotassium ratio will be a sensitive biomarker of antimineralocorticoid activity The dose-response relationship of the antimineralocorticoid activity of PF-03882845 can be established following single oral doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B0171007 | None | None | None |